A Study Using L5 as a Risk Factor of Cardiovascular (CV) Disease in Chronic Renal and Dialytic Patients

China Medical University

Status: Unknown

Conditions: High L5 Level; Chronic Kidney Disease Patients; Hemodialytic Patients; High LDL Level; Cardiovascular Disease

Study type: Observational

Funder types: Other

Identifiers

NCT01236820

CTCHANG001

Details and patient eligibility

About

The purpose of this study is to determine whether L5, one of the Low Density Lipoproteins, is an effective predicting factor for cardiovascular disease in chronic renal and hemodialytic patients.

Full description

Cardiovascular disease (CVD) is the most important cause of death of chronic kidney disease (CKD) and hemodialysis (HD) patients. Low Density Lipoprotein (LDL) is an essential indicator of CVD.The higher the plasma LDL level, the higher the risk of CVD. LDL is a heterogenous substance composed of different mass and size. Oxidized LDL (oxLDL) is the oxidation product of LDL and is the most important component of LDL associated with CVD. The oxLDL is mostly trapped within tissue and not easily to be detected from blood. L5 iw a kind of electronegative LDL and is associated with CVD in smokers and diabetic patients, even if these patients have normal plasma LDL. Uremia patients have lipid profile different from that of general people,while HD Patients have lower LDL and CKD patients have LDL higher than that of general population. Thus LDL plasma level cannot fully explain the high risk of CVD in CKD and HD patients. As patients with normal LDL but high L5 are prone to have CVD, we suspect there might be association of L5 with CVD in both CKD and HD patients.

Enrollment: 48 estimated patients

Sex: All

Ages: 20+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• clinical diagnosis of CKD
• clinical diagnosis of HD

Exclusion criteria

• N/A

Trial design

48 participants in 3 patient groups

Normal

Description:

Healthy population

CKD Patients

Description:

Chronic Kidney Disease, in Stage III-V

HD patients

Description:

End-stage renal disease patients undergoing hemodialysis